id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-D-0219-0009,FDA,FDA-2001-D-0219,Agency Information Collection Activities; Announcement of Office  of Management and Budget Approval; Guidance for Clinical Trial Sponsors: Establishment and Operation of Clinical Trial Data Monitoring Committees,Notice,NAL-Notice of Approval,2006-07-31T04:00:00Z,2006,7,2006-07-28T04:00:00Z,,2010-05-10T16:54:40Z,,0,0,09000064804e4ed0
FDA-2001-D-0219-0007,FDA,FDA-2001-D-0219,Supporting Statement,Supporting & Related Material,SS-Supporting Statement,2006-07-31T04:00:00Z,2006,7,,,2008-04-25T02:28:20Z,,0,0,09000064804e4ecb
FDA-2001-D-0219-0008,FDA,FDA-2001-D-0219,Supporting Statement,Supporting & Related Material,SS-Supporting Statement,2006-07-31T04:00:00Z,2006,7,,,2008-04-25T02:28:19Z,,0,0,09000064804e4ece
FDA-2001-D-0219-0005,FDA,FDA-2001-D-0219,Guidance for Clinical Trial Sponsors: Establishment and Operation of Clinical Trial Data Monitoring Committees; Availability,Notice,NAD-Notice of Availability of Data,2006-03-28T05:00:00Z,2006,3,2006-03-27T05:00:00Z,,2010-05-10T16:50:29Z,,0,0,09000064804e4ec0
FDA-2001-D-0219-0006,FDA,FDA-2001-D-0219,"Guidance for Clinical Trial Sponsors; Establishment and Operation of Clinical Trial Data Monitoring Committees, March 2006",Supporting & Related Material,GDL-Guidance,2006-03-28T05:00:00Z,2006,3,,,2010-05-10T20:21:50Z,,0,0,09000064804e4ec4
FDA-2001-D-0219-0003,FDA,FDA-2001-D-0219,Guidance for Clinical Trial Sponsors; Establishment and Operation of Clinical Trial Data Monitoring Committee December 2005 - Draft Guidance,Supporting & Related Material,GDL-Guidance,2006-01-10T05:00:00Z,2006,1,,,2010-05-10T18:57:16Z,,0,0,09000064804e4e9c
FDA-2001-D-0219-0004,FDA,FDA-2001-D-0219,Agency Information Collection Activities; Submission for Office,Notice,N-Notice,2006-01-10T05:00:00Z,2006,1,,,2010-05-10T16:43:43Z,,0,0,09000064804e4e9e